Gabrielle Fernandes | Director, IR |
William Doyle | Executive Chairman |
Asaf Danziger | President, CEO & Director |
Ashley Cordova | CFO & VP, IR |
Ely Benaim | Chief Medical Officer |
Uri Weinberg | Chief Science Officer |
Pritesh Shah | Chief Commercial Officer |
Jason Bednar | Piper Sandler & Co. |
Lawrence Biegelsen | Wells Fargo Securities |
Vijay Kumar | Evercore ISI |
Gregory Gilbert | Truist Securities |
Jason Wittes | Northland Capital Markets |
Difei Yang | Mizuho Securities |
Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure Third Quarter Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Gabrielle Fernandes, Director of Investor Relations. Please go ahead, ma'am.
Good morning, everyone, and thank you for joining us to review NovoCure's third quarter 2020 performance.